News
Get Instant Summarized Text (Gist) Early use of an intra-aortic balloon pump (IABP) in patients with cardiogenic shock due to heart failure did not improve 60-day survival or facilitate transition ...
Compared with standard medical care, early use of a temporary intra-aortic balloon pump (IABP) to support heart function in patients who were critically ill with cardiogenic shock caused by heart ...
March 27, 2025 /PRNewswire/ -- Johnson & Johnson MedTech, the global leader in heart recovery, will feature the latest evidence demonstrating the survival benefit of Impella ® heart pump ...
Compared with standard medical care, early use of a temporary intra-aortic balloon pump (IABP) to support heart function in patients who were critically ill with cardiogenic shock caused by heart ...
Leveraging the patented technology of the AC3 Optimusâ„¢ IABP, the AC3 Rangeâ„¢ IABP is designed to provide reliable, ongoing IABP support across various patient transport modes, including ...
Systemic Sclerosis Highlights From 2019 ACR Annual Meeting Dr Robert Spiera of the Hospital for Special Surgery in New York City reviews key studies related to systemic sclerosis, presented at the ...
(European Heart Journal) In heart failure complicated by cardiogenic shock, early intra-aortic balloon pump (IABP) placement did not help clinical outcomes in the small randomized trial Altshock-2.
IABP systems are typically inserted within the multidisciplinary environment that is the cardiac catheterization laboratory. The specific role of the physiologist during IABP insertion is to ...
The IABP, developed in the 1960s, was the first device to provide temporary mechanical support to the heart in patients with cardiogenic shock, Sacco said. Although other such devices have been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results